NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Motilal Oswal Maintains Neutral Rating on Shree Cement

Shree Cement's (SRCM) fourth quarter (4QFY26) operating performance was in line with the expectations of Motilal Oswal's research team. The company's earnings before interest, taxes, depreciation, and amortization (EBITDA) declined by approximately 11% year-over-year (YoY) to INR12.5 billion. This decline was primarily due to cost pressure. Additionally, EBITDA per tonne (t) decreased by 19% YoY to INR1,161, which was slightly lower than the estimated INR1,139. The operating profit margin (OPM) contracted by 4.8 percentage points (pp) YoY to approximately 22%.

The adjusted profit after tax (PAT) declined by approximately 8% YoY to INR5.3 billion, which was in line with the research team's expectations. Despite this decline, Motilal Oswal maintained its earnings estimates for the fiscal year 2027 (FY27) and fiscal year 2028 (FY28). The company's valuations are considered fair, with an enterprise value to EBITDA (EV/EBITDA) multiple of 17x for FY27 and 14x for FY28.

CompanyFY26 EBITDA/tFY27 EBITDA/t (Est.)FY28 EBITDA/t (Est.)
Shree CementINR1,174INR1,143INR1,228

Read also: Expert Portfolio Manager Raja Venkatraman Names Top Investment Picks for June 4

Shree Cement's valuations are considered fair, with an enterprise value to EBITDA (EV/EBITDA) multiple of 17x for FY27 and 14x for FY28. Motilal Oswal reiterates its Neutral rating on the company with a target price (TP) of INR26,000, based on an EV/EBITDA multiple of 16x for FY28.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.